Treatment Information

Back

Bladder Cancer treatment details. Chemotherapy.

Hotel-Dieu de France University Hospital, Beirut, Lebanon.

Survival: monthsCountry:Lebanon
Toxiciy Grade:4City/State/Province:Beirut
Treatments:ChemotherapyHospital:Hotel-Dieu de France University Hospital
Drugs:Journal:Link
Date:Sep 2012

Description:

Patients:
This phase 2 study involved 27 advanced urothelial cancer patients. The average patient age was 68 years and 81.5% were male.

Treatment:
Patients were treated with the chemotherapy agents gemcitabine, carboplatin, and paclitaxel.

Toxicities:
The most severe toxicities were of grade 4 and included thrombocytopenia and anemia. Grade 3-4 nausea/vomiting and diarrhea were also reported.

Results:
The median overall survival was 7 months.

Correspondence: Dr. Joseph G. Kattan; email: [email protected]



Back